New Study Shows 84 Percent Decrease in Hospitalization Rates for COVID-19 Patients Treated with Hydroxychloroquine
A new study has demonstrated that treating COVID-19 with hydroxychloroquine makes patients 84 percent less likely to be hospitalized.
The study is set to be published in the International Journal of Antimicrobial Agents in December. It has determined that “low-dose hydroxychloroquine combined with zinc and azithromycin was an effective therapeutic approach against COVID-19.”
The doctors came to their conclusions after treating 141 coronavirus patients with hydroxychloroquine for five days. They compared them with a control group of 377 coronavirus patients who did not receive hydroxychloroquine as a treatment. They found that “the odds of hospitalization of treated patients was 84% less than in the untreated patients.” Only one patient from the group treated with hydroxychloroquine died while 13 people died in the other group.
Big League Politics has reported on the conspiracy by the Big Pharma-funded medical industry to suppress hydroxychloroquine, which has been promoted by President Trump as a cure of sorts for COVID-19:
The doctors responsible for a controversial pro-hydroxychloroquine study are defending their work after it was attacked by National Institute of Allergy and Infectious Diseases (NIAID) director Dr. Anthony Fauci at a recent Congressional hearing.
Drs. Adnan Munkarah and Steven Kalkanis wrote in an open letter that “a whole scientific field exists in which scientists examine how a drug is working in the real world to get as best an answer as they can as soon as possible,” which Dr. Fauci did not acknowledge in his complete dismissal of their work.
Munkarah works as the chief clinical officer of the Henry Ford Health System while Kalkanis works as the chief academic officer for the system. They are standing by their findings and refusing to buckle under the political pressure.
“Our promising Henry Ford treatment study should be considered as another important contribution to the other studies of hydroxychloroquine that describes what the authors found in our patient population,” Munkarah and Kalkanis wrote. “We — along with all doctors and scientists — eagerly support the need for randomized clinical trials.”
“Unfortunately, the political climate that has persisted has made any objective discussion about this drug impossible, and we are deeply saddened by this turn of events,” they wrote, noting they they believe that the science should “speak for itself.”
“To that end, we have made the heartfelt decision to have no further comment about this outside the medical community,” the doctors said.
Munkarah and Kalkanis call for more research to take place but believe that their findings could save lives and should not be discounted.
“As an early hot spot for the COVID-19 pandemic, we have seen and lived its devastating effects alongside our patients and families,” Munkarah and Kalkanis wrote.
“Furthermore, it is not unusual that results from such studies vary in different populations and at different times, and no one study can ever be considered all by itself,” they added.
The elites are suppressing hydroxychloroquine because they want the public to feel helpless against the virus. They never intend to give the public their liberties back, hoping that the public will accept a “new normal” of globalism and technocracy.